|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
956,580,000 |
Market
Cap: |
744.18(B) |
Last
Volume: |
3,208,829 |
Avg
Vol: |
3,310,597 |
52
Week Range: |
$332.64 - $792.28 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 720 |
Guru Rank Value : 1.4 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
656 |
Total Buy Value |
$0 |
$0 |
$0 |
$199,549 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
1 |
Total Shares Sold |
870,750 |
1,086,420 |
3,376,506 |
6,806,173 |
Total Sell Value |
$608,250,580 |
$738,803,096 |
$2,147,483,647 |
$2,147,483,647 |
Total People Sold |
2 |
2 |
5 |
6 |
Total Sell Transactions |
13 |
15 |
49 |
98 |
End Date |
2023-12-28 |
2023-09-26 |
2023-03-28 |
2022-03-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Hedley Mary Lynne |
Director |
|
2024-03-18 |
4 |
A |
$762.66 |
$9,915 |
D/D |
13 |
1,464 |
|
- |
|
Johnson Kimberly H |
Director |
|
2024-03-18 |
4 |
A |
$762.66 |
$9,915 |
D/D |
13 |
2,614 |
|
- |
|
Greene Gabrielle E |
Director |
|
2024-03-18 |
4 |
A |
$762.66 |
$9,915 |
D/D |
13 |
2,115 |
|
- |
|
Alvarez Ralph |
Director |
|
2024-03-18 |
4 |
A |
$762.66 |
$11,440 |
D/D |
15 |
54,013 |
|
- |
|
Luciano Juan R |
Director |
|
2024-03-18 |
4 |
A |
$762.66 |
$14,491 |
D/D |
19 |
15,658 |
|
- |
|
Zakrowski Donald A |
SVP, Finance, & CAO |
|
2024-03-11 |
4 |
AS |
$753.60 |
$565,200 |
D/D |
(750) |
7,880 |
|
5% |
|
Luciano Juan R |
Director |
|
2024-02-20 |
4 |
A |
$755.66 |
$15,113 |
D/D |
20 |
15,612 |
|
- |
|
Hedley Mary Lynne |
Director |
|
2024-02-20 |
4 |
A |
$755.66 |
$9,824 |
D/D |
13 |
1,449 |
|
- |
|
Johnson Kimberly H |
Director |
|
2024-02-20 |
4 |
A |
$755.66 |
$9,824 |
D/D |
13 |
2,597 |
|
- |
|
Alvarez Ralph |
Director |
|
2024-02-20 |
4 |
A |
$755.66 |
$12,091 |
D/D |
16 |
53,906 |
|
- |
|
Greene Gabrielle E |
Director |
|
2024-02-20 |
4 |
A |
$755.66 |
$9,824 |
D/D |
13 |
2,098 |
|
- |
|
Lilly Endowment Inc |
|
|
2024-02-16 |
4 |
S |
$764.29 |
$132,521,930 |
D/D |
(169,684) |
98,898,810 |
|
1% |
|
Lilly Endowment Inc |
|
|
2024-02-15 |
4 |
S |
$760.19 |
$38,263,417 |
D/D |
(50,316) |
99,068,494 |
|
-3% |
|
Weems Alonzo |
EVP, ERM & CECO |
|
2024-02-12 |
4 |
A |
$737.26 |
$701,134 |
D/D |
951 |
7,951 |
|
- |
|
Dozier Eric |
EVP, HR & Diversity |
|
2024-02-12 |
4 |
A |
$737.26 |
$984,979 |
D/D |
1,336 |
7,190 |
|
- |
|
Dozier Eric |
EVP, HR & Diversity |
|
2024-02-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
408 |
5,854 |
|
- |
|
Ashkenazi Anat |
EVP & CFO |
|
2024-02-12 |
4 |
A |
$737.26 |
$3,103,865 |
D/D |
4,210 |
42,330 |
|
- |
|
Zakrowski Donald A |
SVP, Finance, & CAO |
|
2024-02-12 |
4 |
A |
$737.26 |
$924,524 |
D/D |
1,254 |
8,630 |
|
- |
|
Yuffa Ilya |
EVP & President, LLY Intl |
|
2024-02-12 |
4 |
A |
$737.26 |
$3,531,475 |
D/D |
4,790 |
19,802 |
|
- |
|
Van Naarden Jacob |
EVP & Pres., Loxo@Lilly |
|
2024-02-12 |
4 |
A |
$737.26 |
$1,746,569 |
D/D |
2,369 |
16,147 |
|
- |
|
Norton Johna |
EVP, Global Quality |
|
2024-02-12 |
4 |
A |
$737.26 |
$1,229,750 |
D/D |
1,668 |
32,484 |
|
- |
|
White Anne E. |
EVP & Pres, Lilly Neuroscience |
|
2024-02-12 |
4 |
A |
$737.26 |
$3,953,925 |
D/D |
5,363 |
65,569 |
|
- |
|
Hernandez Edgardo |
EVP & Pres., Mfg. Operations |
|
2024-02-12 |
4 |
A |
$737.26 |
$2,079,810 |
D/D |
2,821 |
29,682 |
|
- |
|
Hakim Anat |
EVP, GC & Secretary |
|
2024-02-12 |
4 |
A |
$737.26 |
$4,287,167 |
D/D |
5,815 |
30,479 |
|
- |
|
Ricks David A |
President, Chair, and CEO |
|
2024-02-12 |
4 |
A |
$737.26 |
$28,304,886 |
D/D |
38,392 |
479,250 |
|
- |
|
1437 Records found
|
|
Page 1 of 58 |
|
|